Eosinophilic chronic rhinosinusitis in East Asians

Table 1 Demographic and clinical characteristics of eosinophilic chronic rhinosinusitis with nasal polyps and non-eosinophilic chronic rhinosinusitis with nasal polyps

	ECRSwNP	NECRSwNP
n (%)	27 (45%)	33 (55%)
Age (yr), mean ± SD	46.93 ± 12.35	40.27 ± 13.47
M/F	20/7	24/9
With AR (%)	74.10%	48.5%
With asthma (%)	18.50%	12.1%
Duration of symptom (yr)	5.50 ± 3.92	8.55 ± 6.93
VAS	4.04 ± 1.01	3.99 ± 1.09
Score of olfactory dysfunction	5.59 ± 2.54	5.21 ± 2.66
Score of polyps	3.59 ± 1.11b	2.06 ± 0.82
Incidence of bilateral polyps	92.6%b	39.9%
Score of disease on CT	14.42 ± 3.84b	9.64 ± 3.37
Serum IgE (kU/L)	236.72 ± 157.77	167.97 ± 176.77
Blood eosinophil count (× 109/L)	0.44 ± 0.24b	0.21 ± 0.11
Blood eosinophil percentage (%)	6.49 ± 3.27b	3.42 ± 1.87
Tissue eosinophil count/HPF	31.56 ± 21.37b	0.91 ± 0.80

^bP < 0.01 vs NECRSwNP. ECRSwNP: Eosinophilic chronic rhinosinusitis with nasal polyps; NECRSwNP: Non-eosinophilic chronic rhinosinusitis with nasal polyps; M/F: Male/female; AR: Allergic rhinitis; VAS: Visual analogue scale; HPF: High power field; CT: Computed tomography.